Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon, a Double-Blind Randomized Placebo-Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03639766
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:07.485597+00:00
Published At
2021-06-30T00:00:00+00:00
Record Updated At
2021-06-30
Results Posted At
2021-06-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Raynaud Phenomenon"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-06-30"
protocolSection.identificationModule.nctId
"NCT03639766"
protocolSection.identificationModule.officialTitle
"The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud\u0027s Phenomenon, a Double-Blind Randomized Placebo-Controlled Trial"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-06-30"

Study condition terms

  • Raynaud Phenomenon (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.